Literature DB >> 10533878

Depressive illness.

A Doris1, K Ebmeier, P Shajahan.   

Abstract

WHO estimate that by the beginning of the next century major unipolar depression will be one of the most important causes of ill health overall. Whereas the cause of depression is still obscure, it is becoming clear that a number of diverse factors are likely to be implicated, both genetic and environmental. Effective treatment of depression similarly involves a variety of methods, from electro-convulsive therapy to inter-personal psychotherapy. The pathophysiology of depression is gradually becoming accessible through research strategies, such as functional neuroimaging paired with mood altering interventions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533878     DOI: 10.1016/S0140-6736(99)03121-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

Review 1.  Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis.

Authors:  S-Y Ju; Y-J Lee; S-N Jeong
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

2.  The association between antioxidant intake, dietary pattern and depressive symptoms in older Australian men: the Concord Health and Ageing in Men Project.

Authors:  Arpita Das; Robert G Cumming; Vasi Naganathan; Rosilene V Ribeiro; David G Le Couteur; David J Handelsman; Louise M Waite; Vasant Hirani
Journal:  Eur J Nutr       Date:  2020-05-08       Impact factor: 5.614

3.  Factors associated with subjective quality of life in Korean patients with depressive disorders: the CRESCEND study.

Authors:  Young-Eun Jung; Ho-Jun Seo; Hoo Rim Song; Young Sup Woo; Hyeon-Woo Yim; Hyung-Mo Sung; Min-Soo Lee; Jae-Min Kim; Tae-Youn Jun
Journal:  Qual Life Res       Date:  2011-09-17       Impact factor: 4.147

Review 4.  Escitalopram: a pharmacoeconomic review of its use in depression.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress.

Authors:  Jian-Xin Chen; Li-Hua Yao; Bi-Bo Xu; Kun Qian; Hui-Ling Wang; Zhong-Chun Liu; Xiao-Ping Wang; Gao-Hua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

6.  Modulation of neuronal excitability by serotonin-NMDA interactions in prefrontal cortex.

Authors:  Ping Zhong; Eunice Y Yuen; Zhen Yan
Journal:  Mol Cell Neurosci       Date:  2008-03-25       Impact factor: 4.314

7.  Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety.

Authors:  Fredric Schiffer; Andrea L Johnston; Caitlin Ravichandran; Ann Polcari; Martin H Teicher; Robert H Webb; Michael R Hamblin
Journal:  Behav Brain Funct       Date:  2009-12-08       Impact factor: 3.759

8.  Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Authors:  Paul R Albert; Brice Le François
Journal:  Front Neurosci       Date:  2010-06-17       Impact factor: 4.677

9.  Socioeconomic health inequalities among a nationally representative sample of Danish adolescents: the role of different types of social relations.

Authors:  P Due; J Lynch; B Holstein; J Modvig
Journal:  J Epidemiol Community Health       Date:  2003-09       Impact factor: 3.710

10.  Depression during Pregnancy : Overview of Clinical Factors.

Authors:  Heather A Bennett; Adrienne Einarson; Anna Taddio; Gideon Koren; Thomas R Einarson
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.